Video

Bringing Quality Cancer Care Closer to Home

Author(s):

Edward S. Kim, M.D.

There seems to be a shift in the field of oncology where patients are looking more toward being treated close to home rather than traveling to a large academic treatment center, explained Edward S. Kim, M.D., Chair of the Department of Solid Tumor Oncology at Levine Cancer Institute, at Association of Community Cancer Centers 34th National Oncology Conference.

There seems to be a shift in the field of oncology where patients are looking more toward being treated close to home rather than traveling to a large academic treatment center, explained Edward S. Kim, M.D., Chair of the Department of Solid Tumor Oncology at Levine Cancer Institute, at Association of Community Cancer Centers 34th National Oncology Conference. Kim noted that while the quality of care is usually great at these large hospitals, the frequent travel may have a negative impact on the patients’ quality of life.

Bringing great cancer care closer to patients was one of the main goals in mind when the Levine Cancer Institute was developed, which offers quality, regional care for patients in North and South Carolina. To help clinicians stay up-to-date with the latest treatment and research advanced, 25 community-based oncology groups came together to create EAPathways, a program accessible through smart phones, tablets and desktops.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of bald man.
Image of man.
Image of Kumar.
Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.
Melanoma is a key cancer type for developing and testing immunotherapies prior to broader clinical application across other malignancies.
Image of Dr. Kumar.
Photo of a woman with shoulder-length black hair wearing a blazer
Image of a woman wearing a headband and glasses
Image of man.
Related Content
CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.
April 11th 2025

What Role May ctDNA Have in Melanoma Management?

Dr. Michael K. Wong
CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.
image of dr. Lillian Siu.
April 3rd 2025

Breaking Down Early Signs and Symptoms of Head and Neck Cancer

Dr Lillian Siu
April is Head and Neck Cancer Awareness Month, and it is important to be aware of early signs and symptoms of the disease, as well as when to seek care.
Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer
March 6th 2025

Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer

Ryan Scott
Artificial intelligence aids in polyp detection, enhancing colonoscopy effectiveness and reducing the risk of colorectal cancer progression in patients.
Image of Dr. Fakih.
February 27th 2025

ctDNA Alone ‘Not Sufficient’ When Monitoring Patients With Colorectal Cancer

Dr. Marwan Fakih
The addition of ctDNA testing to radiographic surveillance resulted in curative surgical intervention for 1.6% of patients with colorectal cancer.
Image of doctor with brown hair.
February 25th 2025

Some KRAS Mutations Associated With Worse Outcomes in Pancreatic Cancer

Dr. Vaia Florou
In patients with pancreatic ductal adenocarcinoma, KRAS G12D and G12V mutations hare associated with worse patient outcomes, researchers have found.
Dr. Megan Menon explains how patients can verify the authenticity of online prescription purchases for their cancer treatment.
February 21st 2025

How Patients With Cancer Can Avoid Counterfeit Therapeutics Online

Dr. Megan Menon
Dr. Megan Menon explains how patients can verify the authenticity of online prescription purchases for their cancer treatment.